Literature DB >> 6438627

Guanosine nucleotide binding by highly purified Ha-ras-encoded p21 protein produced in Escherichia coli.

V Manne, S Yamazaki, H F Kung.   

Abstract

High-level expression of the p21 protein product of the BALB murine sarcoma virus v-ras gene (similar to the product of the Harvey murine sarcoma virus v-Ha-ras gene) has been reported recently, and highly purified preparations of this protein have been obtained. We used a nitrocellulose filter assay for measuring the binding of GDP and GTP to the purified protein. Previously p21 antibodies had been used to precipitate p21-guanosine nucleotide complexes from crude extracts containing the protein. Using the filter assay, we find that the v-Ha-ras gene product binds [3H]GDP stoichiometrically. The binding is time-dependent and is faster at 30 degrees C than at 0 degrees C. Optimum binding is obtained in the presence of dithiothreitol and magnesium ions and at pH 7.4. In terms of its GDP binding activity, p21 is heat stable and pronase sensitive. The dissociation constants (Kd) of p21 for [3H]GDP and [3H]GTP, determined by Scatchard analysis, are 6 X 10(-8) M and 2.5 X 10(-8) M, respectively.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438627      PMCID: PMC392054          DOI: 10.1073/pnas.81.22.6953

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Comparison of the genomic organization of Kirsten and Harvey sarcoma viruses.

Authors:  T Y Shih; D R Williams; M O Weeks; J M Maryak; W C Vass; E M Scolnick
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

Review 3.  The meaning of Scatchard and Hill plots.

Authors:  F W Dahlquist
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes.

Authors:  R W Ellis; D Defeo; T Y Shih; M A Gonda; H A Young; N Tsuchida; D R Lowy; E M Scolnick
Journal:  Nature       Date:  1981-08-06       Impact factor: 49.962

6.  Guanine nucleotide binding activity of the src gene product of rat-derived murine sarcoma viruses.

Authors:  E M Scolnick; T Y Shih; J Maryak; R Ellis; E Chang; D Lowy
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

7.  Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma viruses.

Authors:  E M Scolnick; A G Papageorge; T Y Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus.

Authors:  T Y Shih; A G Papageorge; P E Stokes; M O Weeks; E M Scolnick
Journal:  Nature       Date:  1980-10-23       Impact factor: 49.962

9.  Identification of a precursor in the biosynthesis of the p21 transforming protein of harvey murine sarcoma virus.

Authors:  T Y Shih; M O Weeks; P Gruss; R Dhar; S Oroszlan; E M Scolnick
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

10.  Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene.

Authors:  L F Parada; C J Tabin; C Shih; R A Weinberg
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

View more
  27 in total

1.  Interaction of GTPase-activating protein with p21ras, measured using a continuous assay for inorganic phosphate release.

Authors:  M R Webb; J L Hunter
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

2.  Characterization of phosphoinositide-specific phospholipase C from human platelets.

Authors:  V Manne; H F Kung
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

3.  rasH mutants deficient in GTP binding.

Authors:  C J Der; B T Pan; G M Cooper
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

4.  Expression of the Aplysia californica rho gene in Escherichia coli: purification and characterization of its encoded p21 product.

Authors:  P S Anderson; J C Lacal
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

5.  Mutational analysis of a ras catalytic domain.

Authors:  B M Willumsen; A G Papageorge; H F Kung; E Bekesi; T Robins; M Johnsen; W C Vass; D R Lowy
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

6.  Biochemical properties of a highly purified v-rasH p21 protein overproduced in Escherichia coli and inhibition of its activities by a monoclonal antibody.

Authors:  S Hattori; L S Ulsh; K Halliday; T Y Shih
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

7.  Biochemical characterization of polypeptides encoded by mutated human Ha-ras1 genes.

Authors:  W W Colby; J S Hayflick; S G Clark; A D Levinson
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

8.  Structural Dynamics in Ras and Related Proteins upon Nucleotide Switching.

Authors:  Rane A Harrison; Jia Lu; Martin Carrasco; John Hunter; Anuj Manandhar; Sudershan Gondi; Kenneth D Westover; John R Engen
Journal:  J Mol Biol       Date:  2016-10-14       Impact factor: 5.469

9.  Regulation of tetradecanoyl phorbol acetate-induced responses in NIH 3T3 cells by GAP, the GTPase-activating protein associated with p21c-ras.

Authors:  M Nori; G L'Allemain; M J Weber
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

10.  Organ specific expression of ras oncoproteins during growth and development of the rat.

Authors:  T Tanaka; N Ida; H Shimoda; C Waki; D J Slamon; M J Cline
Journal:  Mol Cell Biochem       Date:  1986-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.